In vitro transformation of primary human CD34+ cells by AML fusion oncogenes: Early gene expression profiling reveals possible drug target in AML

Authors

Anmaar M. Abdul-Nabi, Washington University School of Medicine in St. LouisFollow
Enas R. Yassin, Washington University School of Medicine in St. Louis
Nobish Varghese, Washington University School of Medicine in St. Louis
Hrishikesh Deshmukh, Washington University School of Medicine in St. LouisFollow
Nabeel R. Yaseen, Washington University School of Medicine in St. Louis

Journal

PLoS One

Publication Date

2010

Volume

5

Issue

8

Inclusive Pages

e12464

Document Type

Open Access Publication

DOI

10.1371/journal.pone.0012464

Rights and Permissions

Abdul-Nabi AM, Yassin ER, Varghese N, Deshmukh H, Yaseen NR, 2010 In Vitro Transformation of Primary Human CD34+ Cells by AML Fusion Oncogenes: Early Gene Expression Profiling Reveals Possible Drug Target in AML. PLoS ONE 5(8): e12464. doi:10.1371/journal.pone.0012464

Recommended Citation

Abdul-Nabi, Anmaar M.; Yassin, Enas R.; Varghese, Nobish; Deshmukh, Hrishikesh; and Yaseen, Nabeel R., "In vitro transformation of primary human CD34+ cells by AML fusion oncogenes: Early gene expression profiling reveals possible drug target in AML." PLoS One. 5, 8. e12464. (2010).
https://digitalcommons.wustl.edu/open_access_pubs/701